Literature DB >> 22310033

Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms.

Alex J Mitchell1, Karen Lord, Paul Symonds.   

Abstract

BACKGROUND: There have been few studies that have attempted to examine the phenomenology of comorbid depression, in particular the diagnostic value of individual somatic and non-somatic symptoms when attempting to diagnose depression following cancer.
METHODS: We approached 279 patients up to three times within 9 months of first presentation with a diagnosis of cancer, and collected data following a total of 558 contacts. 176 contacts (31%) were in a palliative stage. Symptoms were elicited by self-report PHQ9 and HADS-D scales. The prevalence of major depression was 12.7% but 29.6% had major or minor depression (any depressive disorder) according to modified DSMIV criteria.
RESULTS: All symptoms of depression were significant more common in depressed versus non-depressed cancer patients regardless of stage. Against broadly defined any depressive disorder (ADD) the most accurate diagnostic symptoms were all somatic (namely trouble falling or staying asleep or sleeping too much; feeling tired or having little energy; poor appetite or overeating; trouble concentrating on things such as reading). Indeed the optimal symptom insomnia had good case-finding properties and screening properties used alone. A two step combination of three questions give a sensitivity of 100% and specificity of 91.6% against ADD. Against major depressive disorder (MDD) both somatic and non-somatic symptoms were valuable (including but not limited to the PHQ2 stem questions). Only low energy was poorly discriminating which may suggest that the standard ICD10 criteria may not be optimal. When considering depression as defined by the HADS-D (≥ 11), then the three most influential symptoms were psychological closely followed by somatic symptoms. When looking for MDD and HADS-D depression, no single symptom was a good proxy for depression highlighting a possible shortcoming if clinicians attempt to rely on one single question. In a subset of palliative patients feeling bad about yourself and moving or speaking slowly were less influential and outperformed by poor appetite/overeating and feeling tired or having little energy.
CONCLUSION: This research suggests that most somatic symptoms remain influential when diagnosing depression in the context of cancer and hence should not be omitted indiscriminately, even in palliative stages. The optimal symptoms for diagnosing depression will depend on whether a narrow concept of depression or a broad concept of depression is considered clinically important. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22310033     DOI: 10.1016/j.jad.2011.11.009

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

Review 1.  Towards a new conceptualization of depression in older adult cancer patients: a review of the literature.

Authors:  Rebecca M Saracino; Barry Rosenfeld; Christian J Nelson
Journal:  Aging Ment Health       Date:  2015-08-27       Impact factor: 3.658

2.  Performance of four diagnostic approaches to depression in adults with cancer.

Authors:  Rebecca M Saracino; Barry Rosenfeld; Christian J Nelson
Journal:  Gen Hosp Psychiatry       Date:  2018-01-31       Impact factor: 3.238

3.  Latent Profile Analyses of Depressive Symptoms in Younger and Older Oncology Patients.

Authors:  Rebecca M Saracino; Heining Cham; Barry Rosenfeld; Christian J Nelson
Journal:  Assessment       Date:  2018-06-27

4.  Assessing depression in a geriatric cancer population.

Authors:  Rebecca M Saracino; Mark I Weinberger; Andrew J Roth; Arti Hurria; Christian J Nelson
Journal:  Psychooncology       Date:  2016-05-16       Impact factor: 3.894

5.  A differential item function analysis of somatic symptoms of depression in people with cancer.

Authors:  Salene M W Jones; Evette J Ludman; Ruth McCorkle; Robert Reid; Erin J Aiello Bowles; Robert Penfold; Edward H Wagner
Journal:  J Affect Disord       Date:  2014-09-10       Impact factor: 4.839

6.  Oncologists' perception of depressive symptoms in patients with advanced cancer: accuracy and relational correlates.

Authors:  Lucie Gouveia; Sophie Lelorain; Anne Brédart; Sylvie Dolbeault; Angélique Bonnaud-Antignac; Florence Cousson-Gélie; Serge Sultan
Journal:  BMC Psychol       Date:  2015-03-11

7.  Cytokines and depression in cancer patients and caregivers.

Authors:  Madeline Li; Ekaterina Kouzmina; Megan McCusker; Danielle Rodin; Paul C Boutros; Christopher J Paige; Gary Rodin
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-28       Impact factor: 2.570

Review 8.  Depressive Spectrum Disorders in Cancer: Diagnostic Issues and Intervention. A Critical Review.

Authors:  Rosangela Caruso; Maria GiuliaNanni; Michelle B Riba; Silvana Sabato; Luigi Grassi
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

Review 9.  Depression in cancer patients.

Authors:  S Dauchy; S Dolbeault; M Reich
Journal:  EJC Suppl       Date:  2013-09

10.  Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments.

Authors:  A M H Krebber; L M Buffart; G Kleijn; I C Riepma; R de Bree; C R Leemans; A Becker; J Brug; A van Straten; P Cuijpers; I M Verdonck-de Leeuw
Journal:  Psychooncology       Date:  2013-09-16       Impact factor: 3.894

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.